Skip to main content

We earn commissions from brands listed on this site, which influences how listings are presented. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. States
  3. Indiana
  4. Weight Loss
Telehealth treatment comparison background
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onAugust 20, 2026

Online Weight Loss Treatment in Indiana All 15 Providers Compared for 2026

In Indiana, you'll need a live video consultation before getting a weight loss prescription. Insurance coverage varies by plan.

Fast Approval
Free Shipping
Exclusive Coupons
Online Prescription
Compare weight loss treatment providers in Indiana

Key Takeaways

Best weight loss telehealth in Indiana: Medvi for affordability at $149-$199 per month all-inclusive for compounded semaglutide. Indiana offers full insurance parity, so your online weight loss consultation gets reimbursed at the same rate as an in-person visit - a financial advantage many states don't provide. Clinic Secret, Nurx, and UrWay Health don't operate in Indiana. Fifteen weight loss telehealth providers total serve the state.

Who This Is For

This is for
  • Indiana residents with a BMI over 27 who are ready to meet with a licensed Indiana provider over live video.
  • You want access to 14 Indiana-available weight loss providers without driving to a clinic.
  • You're comfortable completing a required video consultation before starting any prescription treatment.
Not for
  • Not for anyone who cannot schedule or complete a live video call, which Indiana requires before prescribing.
  • Not for those with a history of eating disorders or a BMI under 27, who need a different care path.
  • Not for anyone currently pregnant or planning pregnancy, as most weight loss medications are unsafe during pregnancy.

User Preferences & Indiana Availability

16 licensed telehealth providers offer weight loss programs to Indiana residents. Indiana requires a live video consultation with a licensed in-state provider before any prescription is issued.

Medical Disclaimer: Content is for informational purposes only - not medical advice. Consult a licensed healthcare provider before any treatment. Learn more

Most Popular
1
Ro logo

Free Insurance Check - Zepbound® & Wegovy® 100% Online

  • Full GLP-1 suite: Zepbound®, Wegovy® pill and pen, semaglutide and more
  • Free insurance check shows what your plan covers before you pay
  • Tirzepatide (Zepbound®) averaged up to 20.9% body weight loss in the 72-week SURMOUNT-1 trial; individual results vary
  • On-demand provider coaching and support, 100% online
LegitScript verifiedView
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
32,100 User Votes
See PricingRead full review
Our Top Choice
2
Medvi logo

Doctor-Guided GLP-1 From $179/mo - Free Dietician Visits Included

  • Doctor-guided GLP-1 care, 100% online - no waiting rooms
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
33,200 User Votes
See PricingRead full review
3
Strut logo

Start for Free - Free MD Visit, Follow-Up Care & Shipping

  • Compounded injectable semaglutide prescribed by U.S.-licensed physicians
  • Free online MD visit and free follow-up care included
  • Free shipping - fill through Strut's pharmacy network or your local pharmacy
  • Your Strut doctor manages your dosage increase plan as treatment progresses
LegitScript verifiedView
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
38,500 User Votes
See PricingRead full review
4
Fridays logo

Summer Sale: Semaglutide From $117/mo - Save Up to 50% Off Retail

  • Compounded semaglutide from $117/mo, tirzepatide from $198/mo
  • Summer sale: save up to 50% off retail (codes NEWYOU12 / NEWYOU3)
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
LegitScript verifiedView
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
8,900 User Votes
See PricingRead full review
5
Sprout Health logo

Compounded Semaglutide From $199/mo - Free 2-Minute Quiz

  • Compounded semaglutide and tirzepatide from $199/mo
  • Prescribed by US-licensed clinicians with personalized dosing - no waiting room
  • Ships from a US pharmacy in discreet, refrigerated packaging
  • Members self-reported an average 6.4% body weight loss in the first 12 weeks (individual results vary)
LegitScript verifiedView
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
24,800 User Votes
See PricingRead full review
6
HealthRx logo

Compounded GLP-1 From $99/mo - 30-Day Money-Back Guarantee

  • Compounded semaglutide & tirzepatide GLP-1, from $99/mo on the 12-month plan ($133/mo for 3 months)
  • No insurance needed - full refund if a licensed provider doesn't approve you
  • LegitScript-certified (Cert. 50087439), physician-supervised online intake
  • Ships from US pharmacies in 24-48 hours with fast, free delivery
LegitScript verifiedView
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
12,000 User Votes
See PricingRead full review
7
Skinny.Rx logo

25% Lower Prices on All GLP-1s - Semaglutide From $149.25/mo

  • Compounded injectable semaglutide from $149.25/mo, tirzepatide tablets from $224.25/mo
  • FDA-approved Wegovy® and other GLP-1s available, plus daily oral options via membership
  • Clinician-guided care, not just a prescription - ongoing dose adjustments and provider check-ins
  • App with care team support, medication reminders and weight trend tracking
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
4,378 User Votes
See PricingRead full review
View 5 More Weight Loss Providers
8
Hers logo

GLP-1 Lineup From $149/mo - No Price Markups

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Doctor-trusted GLP-1s including name-brand FDA-approved options, no price markups
  • Personal plan with ongoing care from day 1 via membership
LegitScript verifiedView
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
29,800 User Votes
See PricingRead full review
Our Top Choice
9
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
LegitScript verifiedView
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
33,000 User Votes
See PricingRead full review
10
Hims logo

GLP-1 Lineup From $149/mo - No Price Markups

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Doctor-trusted GLP-1s including name-brand FDA-approved options, no price markups
  • Personal plan with on-demand care from day 1 via membership
LegitScript verifiedView
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
34,200 User Votes
See PricingRead full review
11
Shed logo

Semaglutide From $159/mo - 120-Day Money-Back Guarantee

  • Compounded semaglutide as low as $159/mo, tirzepatide from $239/mo
  • 120-day money-back guarantee - refund if you don't lose 10%, per Shed's terms
  • 100% online visit and checkout - prescription shipped straight to your door
  • Health coaching support included alongside your GLP-1 program
LegitScript verifiedView
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
7,500 User Votes
See PricingRead full review
12
Sesame Care logo

Cash-Pay GLP-1s From $149/mo - Care Plans From $59/mo

  • Cash-pay GLP-1 medications as low as $149/mo, insurance accepted for weight loss meds
  • Ongoing video visits, dedicated provider, labs and messaging from $59/mo
  • 1M+ patients treated with 95% patient satisfaction
LegitScript verifiedView
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
25,400 User Votes
See PricingRead full review
Our Top Choice
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
33,000 reviews
Visit TrimRx

About This Comparison

Our Editorial Standards

This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated August 20, 2026
Licensed Providers OnlyAll listed services are US-licensed

Online Weight Loss Treatment in Indiana: All 15 Providers Compared for 2026

Eric GoldWritten by Eric GoldEditor-in-Chief
18 min readUpdated August 20, 2026

Table of Contents

15 telehealth weight loss providers operate in Indiana in 2026. Compare pricing, medications, and insurance options including Wegovy, semaglutide, and tirzepatide.

Which Weight Loss Providers Actually Work in Indiana

Fifteen telehealth weight loss platforms are active in Indiana right now: Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. Three services that get frequent search traffic are not available here. Clinic Secret, Nurx, and UrWay Health do not operate in Indiana, so if you have seen those names mentioned in a forum or comparison article, you can cross them off your list immediately.
This is a stronger lineup than many Midwestern states see. You have genuine choices across every budget and treatment style: self-pay compounding programs starting under $200 a month, platforms built to fight insurance denials for brand-name Wegovy, and marketplace options where you pay per visit with no subscription commitment. The sections below break down what each approach actually costs in Indiana and who each one makes sense for.
One thing that separates Indiana from states like Texas or Florida is that Indiana has full telehealth insurance parity. Your insurance company is legally required to reimburse an online weight loss consultation at the same rate it would pay for an in-person visit. That changes the math on several providers here, especially PlushCare and Henry Meds, which are built around insurance billing.

Indiana's Insurance Parity Law and What It Means for Your Weight Loss Costs

Indiana is one of the states with full telehealth insurance parity, and that is not a small thing when you are looking at weight loss treatment. It means your insurer cannot pay less for a telehealth visit with an online weight loss doctor than it would for the same visit in a cardiologist's waiting room. In practice, if your plan covers obesity medicine consultations at all, you are not penalized for doing them online.
Indiana Medicaid also covers telehealth weight loss consultations, which matters if you are on Hoosier Healthwise, Healthy Indiana Plan, or another Medicaid managed care plan. The caveat most relevant to weight loss: Medicaid coverage of GLP-1 medications like Ozempic or Wegovy in Indiana is limited and requires prior authorization with documented comorbidities. Hair loss treatments are generally excluded from Medicaid coverage, but that is not relevant to weight loss specifically.
If you have commercial insurance through an Indiana employer, your best starting points are Henry Meds and PlushCare. Henry Meds is specifically built around getting Ozempic and other GLP-1s covered by insurance for diabetes and weight loss overlap cases. PlushCare takes insurance for primary care visits and can prescribe weight loss medications within a covered appointment. Ro also has a dedicated insurance navigation team that will chase prior authorizations for brand-name Wegovy on your behalf, which is worth a lot if your employer plan technically covers it but makes the approval process intentionally difficult.

The Most Affordable Weight Loss Programs for Indiana Residents Paying Out of Pocket

If you are uninsured or your insurance will not cover GLP-1 medications, Medvi is the most straightforward budget option in Indiana. Their all-inclusive pricing for compounded semaglutide runs $149 to $199 per month, and that price covers the medication, the prescriber consultation, and ongoing follow-up. There are no separate pharmacy fees or surprise add-ons. With a rating of 8.9 out of 10 from over 33,200 verified reviews, it is the top-rated platform specifically built for weight loss affordability in Indiana.
Skinny.Rx is another budget-focused option with straightforward monthly pricing for compounded semaglutide. The review base is smaller at around 4,378 verified reviews, but the pricing model is similarly transparent. If Medvi is sold out or has a waitlist in your area, Skinny.Rx is a reasonable fallback. Shed is worth knowing about too, sitting at $8.7 out of 10 from 7,500 reviews, offering compounded GLP-1 medications with behavioral coaching built in. If you want a little more structure than a pure prescription-and-ship model, Shed adds that layer without jumping to premium pricing.
Sesame Care takes a different approach entirely. It is a pay-per-visit marketplace, meaning you pay for individual consultations rather than a monthly subscription. If you need a one-time evaluation to get a prescription started, or if you already have a pharmacy source and just need a licensed Indiana prescriber to write the order, Sesame Care is often the most cost-efficient route. There is no ongoing membership fee, which helps if you are not sure you want to commit to a program yet.

Getting Semaglutide and Tirzepatide in Indiana: Brand Names vs. Compounded

Indiana residents can access both brand-name and compounded versions of GLP-1 medications through telehealth. The brand-name options are Wegovy and Ozempic for semaglutide, and Zepbound for tirzepatide. Compounded versions of both semaglutide and tirzepatide are available through licensed 503B pharmacies, which are the federally-regulated facilities that compound medications at scale. Indiana telehealth providers sourcing from 503B pharmacies are operating within the legal framework, so you do not need to worry about the regulatory gray area that surrounds some compounding arrangements in other states.
The reason compounded GLP-1s exist at all is a supply chain issue that has stretched for years. When the FDA lists a drug as in shortage, licensed compounders are permitted to produce that medication. Both semaglutide and tirzepatide have been on shortage lists, which is what made platforms like Medvi, MyStart Health, Sprout Health, and Shed viable. The FDA periodically updates shortage status, and if the shortage ends for a particular drug, compounders are required to wind down production. This is worth keeping in mind when you are choosing a provider: platforms like Ro and Henry Meds that can also handle brand-name prescriptions give you a fallback if compounded availability shifts.
Compounded semaglutide in Indiana through the most affordable providers runs roughly $149 to $199 per month. Brand-name Wegovy without insurance can run $1,300 to $1,500 per month at retail, which is why the insurance navigation services from Ro and Henry Meds are genuinely valuable if your employer plan covers weight loss medications. Compounded tirzepatide tends to be priced slightly higher than semaglutide through most platforms. If you are specifically searching affordable tirzepatide in Indiana, MyStart Health and Sprout Health are among the platforms offering it with all-inclusive monthly pricing.

Can You Get Phentermine Online in Indiana?

Phentermine is a controlled substance, which means its prescribing rules are different from semaglutide or metformin. Under current DEA regulations, controlled substances can be prescribed via telehealth without an in-person visit, but only if the provider is using a platform that meets specific requirements for identity verification and prescriber registration. Not every telehealth platform prescribes phentermine, partly because of the administrative burden and partly because many weight loss platforms have shifted focus entirely to GLP-1s.
Indiana does not have additional state-level restrictions on phentermine beyond the federal DEA rules, which is helpful. This means that if you find a licensed Indiana telehealth prescriber on a compliant platform, you can get phentermine prescribed online in Indiana. PlushCare and Peter MD are among the platforms operating in Indiana that have broader prescription authority, including controlled substances, compared to platforms that only handle GLP-1 medications. Sesame Care's marketplace model also gives you access to licensed Indiana physicians who can evaluate you for phentermine.
Keep in mind that phentermine is typically prescribed short-term, usually 12 weeks or less, and is most commonly used as a bridge or for patients who are not candidates for GLP-1s. The standard BMI threshold applies in Indiana: 30 or above without a comorbidity, or 27 and above with a documented condition like hypertension, type 2 diabetes, or sleep apnea. If you are right at that threshold, leading with your comorbidity in your intake form matters for getting approved.

The Highest-Rated Weight Loss Platforms Available in Indiana Right Now

Looking purely at verified review ratings among Indiana-available providers, Hims and Strut both sit at 9.0 out of 10 from large review bases (34,200 and 38,500 reviews respectively). Hims is the stronger choice for weight loss specifically because it has a dedicated weight loss program with compounded semaglutide, a clean mobile app experience, and transparent pricing. Strut's 9.0 rating comes largely from its hair loss and men's health compounding products, which are excellent, but it is not primarily a weight loss platform.
Ro and Medvi are both rated 8.9 out of 10. Ro's strength is its breadth: it handles the full insurance navigation process for brand-name Wegovy, has licensed Indiana clinicians on staff, and covers other conditions like ED and hair loss under one account if you want that convenience. Medvi's strength is pure price: it is one of the lowest monthly costs for compounded semaglutide in Indiana, and it is explicitly rated as the top choice by verified reviewers who prioritize weight loss specifically.
Hers, rated 8.8 out of 10 from nearly 30,000 reviews, is worth highlighting separately for Indiana women searching for weight loss treatment. It is a women's health platform that includes weight loss alongside birth control, hair loss, and mental health services. If you want a single telehealth relationship that covers multiple health concerns rather than having separate accounts for each, Hers makes that practical. MyStart Health at 8.6 is specifically positioned as the best option for people new to GLP-1 medications and telehealth weight loss programs, offering more structured onboarding and lifestyle coaching than the leaner budget platforms.

Why Weight Loss Telehealth Access Looks Different in Indiana Than in Coastal States

Indiana has a documented obesity rate that consistently ranks among the higher ones nationally, and the state's healthcare infrastructure, particularly in rural areas like the northern lake counties, southern agricultural regions, and smaller cities between Indianapolis and Fort Wayne, is stretched thin for in-person obesity medicine specialists. There are relatively few board-certified obesity medicine physicians practicing in Indiana outside of major health systems like IU Health or Ascension. Telehealth weight loss programs are not a luxury add-on here for many Indiana residents: they are the most practical way to access a prescriber with weight loss expertise at all.
That context makes Indiana's full insurance parity law more consequential than it might be in a state like New York or California where there are more in-person options. The parity law means that Indiana insurers cannot push you toward an in-person visit as a condition of coverage for telehealth weight loss consultations. If your plan covers weight loss treatment, online counts equally.
Indiana residents in Indianapolis, Fort Wayne, Evansville, South Bend, and Carmel have the same access to all 15 providers listed here as anyone in a major metro. The telehealth model removes geography from the equation entirely. What it does not remove is the insurance pre-authorization process for GLP-1s, which is the same challenge Indiana residents face whether they use an online provider or walk into an IU Health clinic. The advantage of platforms like Ro and Henry Meds is that they have teams whose entire job is managing that prior authorization process, something a solo telehealth prescriber or a busy primary care practice is often too stretched to handle well.

Matching the Right Indiana Weight Loss Provider to Your Situation

If your priority is the lowest monthly cost and you want compounded semaglutide with no extra fees, start with Medvi at $149 to $199 per month. It earns the top choice designation from reviewers for exactly this reason: it is lean, effective, and priced well below what you would pay at a direct-to-consumer pharmacy filling a brand-name prescription.
If you have Indiana commercial insurance and want to try to get brand-name Wegovy or Ozempic covered, go to Ro or Henry Meds first. Ro is built for exactly this, with a team that handles insurer communication on your behalf. Henry Meds is particularly strong if you have a diabetes diagnosis or pre-diabetes alongside your weight concern, since Ozempic is primarily approved for type 2 diabetes management and insurance approval is more straightforward in that context.
If you are new to weight loss medications and want hand-holding through the process, including nutritional coaching and check-ins, MyStart Health is the right starting point. It is rated best for beginners for a reason. If you want the highest-rated broad platform with a strong mobile experience and do not need insurance navigation, Hims for men or Hers for women are the options to look at. If you want no subscription commitment and just need a consultation to get started, Sesame Care's pay-per-visit model in Indiana removes all the recurring cost risk while you figure out whether this treatment approach works for you.

Beyond Semaglutide: Other Weight Loss Medications Available Through Indiana Telehealth

Indiana telehealth prescribers can write for the full range of FDA-cleared weight loss medications, not just GLP-1s. Liraglutide (the daily injectable sold as Saxenda for weight loss) is available and is sometimes chosen when semaglutide is back-ordered or when a prescriber wants to start someone at a lower potency. Metformin is frequently prescribed off-label for weight management, particularly in pre-diabetic patients, and it is inexpensive enough that even without insurance it is rarely a budget concern.
Bupropion-naltrexone, sold as Contrave, is another option available through Indiana telehealth platforms. It works differently from GLP-1s, targeting brain pathways related to appetite and reward rather than gut hormones. Some providers prefer it for patients who have cardiovascular contraindications to GLP-1s or who prefer a daily oral pill to an injectable. Peter MD and PlushCare are among the Indiana-available platforms most likely to offer this range of options, given their broader scope beyond GLP-1 specialty.
Tirzepatide through Zepbound (brand) or compounded tirzepatide is the other major GLP-1 option beyond semaglutide. Clinical trial data showed tirzepatide producing larger average weight loss than semaglutide in head-to-head comparisons, which is why there is so much search interest for affordable tirzepatide in Indiana specifically. Compounded tirzepatide is available through several Indiana-active platforms including MyStart Health and Sprout Health. Pricing is typically slightly higher than compounded semaglutide, but it is still a fraction of Zepbound's retail price without insurance.

Frequently Asked Questions

How many telehealth weight loss providers are available in Indiana?

Fifteen telehealth weight loss platforms are currently available to Indiana residents: Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. Three platforms that come up in online searches do not serve Indiana: Clinic Secret, Nurx, and UrWay Health. If you have been looking at comparison articles that include those three, they are not options you can actually sign up for from an Indiana address. The 15 that do operate here cover the full range from budget compounding programs under $200 per month to insurance-navigating platforms for brand-name Wegovy.

Is Ro available in Indiana and does it help with insurance for Wegovy?

Yes, Ro is fully available in Indiana and it is one of the stronger choices if you have commercial insurance that may cover Wegovy. Ro has a dedicated team that manages prior authorization paperwork with your insurer, which matters because insurance approvals for GLP-1 weight loss medications typically require documentation of BMI, comorbidities, and prior treatment attempts. Indiana's insurance parity law means your insurer must treat a Ro telehealth consultation the same as an in-person visit financially. If your prior authorization is denied, Ro can support an appeal. Ro is rated 8.9 out of 10 from 32,100 verified reviews and is one of the most visible platforms for Indiana residents searching for Wegovy access.

What is the cheapest weight loss medication program available in Indiana?

Medvi offers the lowest all-inclusive pricing for compounded semaglutide in Indiana, running $149 to $199 per month with no separate pharmacy fees or consultation add-ons. That price includes the medication, prescriber evaluation, and ongoing follow-up. Medvi is rated 8.9 out of 10 from over 33,200 verified reviews and is the platform most specifically recommended for Indiana residents prioritizing cost. Skinny.Rx is another budget option with transparent monthly pricing and a smaller but positive review base. If you want to avoid a subscription entirely, Sesame Care's pay-per-visit model can reduce your upfront commitment while you evaluate whether GLP-1 treatment is right for you.

Can I get phentermine prescribed online in Indiana?

Yes, phentermine can be prescribed via telehealth in Indiana. Phentermine is a Schedule IV controlled substance, so the prescribing platform must comply with DEA telehealth rules around identity verification and prescriber registration. Indiana does not add state-level restrictions beyond the federal requirements. Platforms operating in Indiana that have broader prescription authority, including controlled substances, include PlushCare and Peter MD. The standard eligibility threshold applies: BMI of 30 or higher, or 27 and above with a documented comorbidity like hypertension or type 2 diabetes. Phentermine is typically prescribed for short durations, usually no more than 12 weeks, and some providers use it alongside GLP-1 therapy.

Does Indiana Medicaid cover weight loss medications prescribed through telehealth?

Indiana Medicaid covers telehealth consultations for weight loss due to the state's full insurance parity rules, so the visit itself is covered under Hoosier Healthwise and Healthy Indiana Plan managed care options. Medication coverage is more complicated. GLP-1 medications like Ozempic may be covered for diabetes management under Indiana Medicaid with prior authorization, but coverage for weight loss as the primary indication is more restricted and varies by managed care plan. Compounded semaglutide and tirzepatide are generally not covered by Medicaid at all. If you are on Indiana Medicaid and need weight loss medication, Henry Meds or PlushCare are the most relevant platforms for insurance billing, and a consultation will clarify exactly what your specific plan will approve.

What is the clinical BMI threshold to qualify for weight loss medication in Indiana?

The standard clinical threshold applied by Indiana telehealth providers mirrors national guidelines: a BMI of 30 or above qualifies without any other conditions required. If your BMI is between 27 and 29.9, you still qualify if you have at least one documented weight-related comorbidity such as type 2 diabetes, pre-diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or non-alcoholic fatty liver disease. This threshold applies regardless of which platform you use. When you complete your intake form, be specific about comorbidities if your BMI is in the 27 to 29 range. Providers cannot prescribe based on BMI alone if you are below 30, so that documentation matters for approval.

Is compounded semaglutide legal and safe to use in Indiana?

Compounded semaglutide is legal in Indiana when it is produced by a licensed 503B outsourcing facility and prescribed through a licensed Indiana telehealth provider. 503B pharmacies are federally regulated by the FDA and must meet pharmaceutical-grade manufacturing standards. The legal basis for mass compounding of GLP-1s rested on FDA shortage designations for semaglutide and tirzepatide, which the FDA declared resolved in December 2024 and February 2025; compounding now depends on patient-specific clinical need. Indiana residents using platforms like Medvi, MyStart Health, Sprout Health, Shed, or Skinny.Rx are getting compounded semaglutide through this framework. You should ask any provider you are evaluating whether they source from a 503B facility specifically, since that distinction matters for safety and legal compliance.

How does Indiana's telehealth insurance parity law affect the cost of weight loss treatment?

Indiana's full telehealth insurance parity law means your insurer must reimburse an online weight loss consultation at the same rate it would pay for an identical in-person visit. You cannot be charged a higher copay or coinsurance because the visit happened over video or phone. For Indiana residents with commercial insurance from an employer plan, this makes telehealth weight loss consultations through PlushCare or Henry Meds financially equivalent to visiting a local obesity medicine specialist, if your plan covers that service at all. It also means insurers cannot deny coverage for telehealth specifically. This parity protection does not extend to the medications themselves, where prior authorization requirements still apply regardless of how you received the prescription.

Which Indiana weight loss telehealth platform is best for women?

Hers is the strongest option for Indiana women who want a platform designed specifically around women's health. It covers weight loss alongside birth control, hair loss, mental health support, and general wellness under one account, rated 8.8 out of 10 from nearly 30,000 verified reviews. If weight loss is your only concern and cost is the priority, Medvi works equally well regardless of gender at its $149 to $199 monthly price point. MyStart Health is the best option for Indiana women who are new to GLP-1 medications and want structured coaching and lifestyle support alongside the prescription, rather than a medication-only approach.

What is the difference between Wegovy and compounded semaglutide available in Indiana?

Wegovy is the FDA-approved brand-name version of semaglutide specifically indicated for weight management, manufactured by Novo Nordisk. It goes through FDA approval, and every batch meets consistent potency and formulation standards. Compounded semaglutide available through Indiana telehealth providers is made by licensed 503B pharmacies and contains semaglutide, the active ingredient in Wegovy, but it is not FDA-approved as a finished drug product and is not reviewed by the FDA for safety, effectiveness, or quality. The practical differences for most Indiana residents come down to cost and insurance. Wegovy without insurance runs $1,300 to $1,500 per month at retail. Compounded semaglutide through Medvi or comparable Indiana platforms runs $149 to $199 per month. Insurance will only cover brand-name Wegovy, not compounded versions, which is why platforms like Ro and Henry Meds focus on insurance navigation for brand-name access.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.

  • CCHP Telehealth Policy - IndianaIndiana state telehealth laws, online prescribing rules, and insurance reimbursement policies maintained by the Center for Connected Health Policy.
  • CDC - Adult Obesity FactsCDC data: over 40% of U.S. adults have obesity, with $173 billion in annual medical costs. National prevalence and demographic breakdowns.
  • NIDDK - Weight ManagementNIDDK evidence-based guidance on weight management: BMI thresholds, GLP-1 medications, and health risks of obesity.
  • America's Health Rankings - Cardiovascular Health in IndianaIndiana cardiovascular disease prevalence, including heart attack, stroke, and coronary heart disease.
  • America's Health Rankings - Diabetes in IndianaIndiana diabetes prevalence among adults, sourced from CDC BRFSS data.
  • NIMH - Mental Illness StatisticsNIMH data: 1 in 5 U.S. adults experience mental illness annually. National prevalence by condition, age, and demographic.
  • America's Health Rankings - Physical Inactivity in IndianaIndiana adult physical inactivity rate — percentage reporting no exercise beyond their regular job.
  • America's Health Rankings - Obesity in IndianaIndiana adult obesity prevalence data from the CDC Behavioral Risk Factor Surveillance System.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
33,000 reviews
Visit TrimRx

Compare Top Weight Loss Providers

See how the top weight loss providers in Indiana stack up against each other:

Ro vs MedviRo vs StrutRo vs FridaysView All Comparisons →

More Telehealth Options in Indiana

Explore other telehealth treatments available in Indiana:

Erectile Dysfunction in IndianaHair Loss in IndianaWomens Health in IndianaPremature Ejaculation in IndianaMental Health in IndianaWeight Loss NationwideGLP-1 Price Index 2026How to Get Ozempic Without Insurance (2026 Guide)All Indiana TreatmentsBrowse All States →
Eric Gold
Eric GoldEditor-in-Chief

Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

Medical Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Telehealth regulations in Indiana may change. Always verify requirements with your chosen provider. Read our full medical disclaimer.

Regulatory noticeRegulatory note (verified August 22, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that "Same active ingredient as Wegovy and Ozempic" and "Same active ingredient as Mounjaro and Zepbound" implied an FDA approval compounded drugs do not have. We found no close-out letter, so the matter appears open. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. Three site claims are also quoted, among them "Generic Zepbound, Mounjaro" and "Semaglutide is the active ingredient in the brand medications." Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. FDA’s warning letter index shows no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): One sentence is all that FDA warning letter MARCS-CMS 715879 quotes. Sent to Sprout Health Partners LLC on September 9, 2025 after an August 2025 review of joinsprouthealth.com, it cites the line "GLP-1 medications are FDA-approved and backed by extensive clinical research..." Appearing on pages offering compounded semaglutide and tirzepatide, that statement implied to the agency that the compounded products themselves are FDA-approved, which they are not, and it was cited as misbranding under FD&C Act 502(a) and 502(bb). A search of FDA’s warning letter index turns up no close-out letter, so the matter appears open. Read the FDA letter

Verification limitationVerification note (checked August 23, 2026): we could not identify the legal entity behind HealthRx through public records. Its website does not name an operating company, its domain registration is privacy-shielded, and we could not confirm a listing in any business registry or accreditation database we checked. This is not a finding of wrongdoing. It means our usual checks, including our search of FDA enforcement records, could only be run against the brand name and domain rather than a confirmed company.

Regulatory noticeRegulatory note (verified August 22, 2026): Skinny.Rx operates as SkinnyRx, but the legal entity is Lean Rx, Inc., and that is the name on FDA warning letter MARCS-CMS 717989, dated February 20, 2026. Following a December 2025 review of skinnyrx.com, the agency objected to the "SkinnyRx" name on pictured labels, saying it implies SkinnyRx compounds the drugs itself, and to three marketing lines, including "Get access to the same active ingredient as name-brand GLP-1 medications" and "It contains the same active ingredient as FDA-approved medications." Compounded semaglutide and tirzepatide are not FDA-approved, so the FDA read those lines as implying an approval that does not exist and classed the products as misbranded. No close-out letter is posted; read the matter as unresolved. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter